Ledger.Open graph →
SEC Form D · filed June 6, 2017

Harpoon Therapeutics, Inc

Offering
$45.2M
Sold
$25.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Ron E. Hunt · South San Francisco, CADirectorMark E. Chin · South San Francisco, CADirectorPatrick E. Baeuerle · South San Francisco, CADirectorLuke E. Evnin · South San Francisco, CADirectorDan E. Hicklin · South San Francisco, CADirectorGerald Mcmahon · New Haven, CTExec · DirectorPablo E. Cagnoni · South San Francisco, CADirectorWilliam E. Picht · South San Francsico, CAExecRon E. Hunt · South San Francisco, CADirectorMark E. Chin · South San Francisco, CADirectorPatrick E. Baeuerle · South San Francisco, CADirectorGerald Mcmahon · New Haven, CTExec · DirectorLuke E. Evnin · South San Francisco, CADirectorPablo E. Cagnoni · South San Francisco, CADirectorWilliam E. Picht · South San Francsico, CAExecDan E. Hicklin · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗